MedPath

Evaluation of effeciveness of nebulized Ketamin in treatment of asthma attack.

Phase 2
Conditions
Asthma attack.
??? ??? ????
Registration Number
IRCT2015052922468N1
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
63
Inclusion Criteria

Inclusion criteria: 63 patients between 18 and 65 years old in acute asthma attack going to Rasoul Akram , Firoozgar, Haftom Tir hospital, who do not have the exlusion criteria.
Exclusion criteria: patients younger than 18 years old and older than 65 years old; Ischemic heart disease; Pneumothorax; Severe respiratory distress with scyanosis or decreased level of consciousness; Pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FEV1. Timepoint: Minutes 0,30,60,120. Method of measurement: By Spirometry.;Heart rate. Timepoint: Minutes 0, 30, 60, 120. Method of measurement: Counting heart rate in one minute.;Respiratory rate. Timepoint: Minutes 0, 30, 60, 120. Method of measurement: Counting respiratory rate in one minute.
Secondary Outcome Measures
NameTimeMethod
Change in consiousness. Timepoint: Minutes 0, 30, 60, 120. Method of measurement: physical exam.;Diplopia. Timepoint: Minutes 0, 30, 60, 120. Method of measurement: physical exam.
© Copyright 2025. All Rights Reserved by MedPath